Clinical Trial

Redo-Pulmonary Vein Isolation With Versus Without Posterior Wall Ablation - The REDO-PIFPAF-PFA Study

Name: Redo-Pulmonary Vein Isolation With Versus Without Posterior Wall Ablation - The REDO-PIFPAF-PFA Study — clinical trial record (NCT07745543)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The study will compare two ablation strategies in patients with paroxysmal or persistent atrial fibrillation undergoing repeat ablation using pulsed-field ablation: redo pulmonary vein isolation only versus redo pulmonary vein isolation with added posterior wall ablation.

Trial Details

NCT Number	NCT07745543
Lead Sponsor	University Hospital, Basel, Switzerland Collaborators: Swiss Heart Foundation, Boston Scientific Corporation
Conditions	Atrial Fibrillation (AF)
Enrollment	270 participants
Start Date	2026-08
Primary Completion	2031-07 (estimated)
Study Completion	2031-07 (estimated)
Updated on ClinicalTrials.gov	2026-08-04